TLX Competitors & Alternatives
Compare Telix Pharmaceuticals Limited with similar stocks in the same industry
Biotechnology
TLX
Main Stock$9.45
Tradestie Score
48
Market Cap
$3.40B
P/E Ratio
111.6
Revenue Growth
0.2%
Analyst Upside
+119.8%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PTGX
Protagonist Therapeutics, Inc
|
$139.14
|
$3.98B | 134.0 | 66 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$110.56
|
$3.91B | - | 54 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$22.64
|
$3.83B | - | 61 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$14.90
|
$3.68B | - | 49 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$83.26
|
$3.67B | - | 63 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$11.04
|
$3.59B | 16.0 | 27 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$20.30
|
$3.58B | 8.9 | 71 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$309.89
|
$3.49B | 32.3 | 52 | Compare |
|
QURE
uniQure N.V.
|
$23.60
|
$3.39B | - | 63 | Compare |
More TLX Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry